Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years (Q35918834)

From Wikidata
Jump to navigation Jump to search
scientific article published in December 2011
edit
Language Label Description Also known as
English
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years
scientific article published in December 2011

    Statements

    Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years (English)
    Mark H Einstein
    Archana Chatterjee
    Nahida Chakhtoura
    Dorothée Meric
    Francis J Dessy
    Sanjoy K Datta
    Dominique Descamps
    HPV-010 Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit